Insiders offered extra Tempus AI TEM -8.37% ▼ inventory final week as shares of the medical expertise agency proceed to notch a collection of contemporary all-time highs. TEM, which is up 161% in 2025 to date, has been one of many stand-out shares within the AI sector, which has seen appreciable volatility this 12 months amid the launch of China’s DeepSeek fashions, mega spending plans by large tech and the brand new Trump administration’s Stargate challenge.
TEM Record High
TEM stock has benefitted investor enthusiasm over American politician Nancy Pelosi’s buy of fifty name choices in January, and the Trump Administration’s AI funding by way of the Stargate initiative. TEM inventory has continued to rise and hit contemporary all-time highs on Friday, February 14th.
The newest rally got here after TEM introduced a challenge to develop remedies for follicular lymphoma (FL), a slow-growing most cancers that impacts the immune system. Eric P. Lefkofsky, CEO and Chairman of Tempus AI, and a ten% proprietor, offered 243,545 shares of Class A Widespread Inventory, with transactions totaling $18,981,317. The gross sales, supposed to cowl tax obligations from vested restricted inventory models, had been executed at weighted common costs starting from $70.02 to $87.37. Following these transactions, Lefkofsky instantly owns 5,049,460 shares and not directly controls 43,224,176 shares by way of varied entities.
Jennifer A. Doudna, a Director at Tempus AI, offered 1,320 shares at a value of $90.0 per share, totaling $118,800. Following this sale, Doudna instantly owns 36,011 shares of Tempus AI. This transaction was executed below a Rule 10b5-1 buying and selling plan adopted on August 28, 2024.
In collaboration with Genialis, Tempus AI can also be engaged on validating new RNA-based biomarker algorithms throughout totally different most cancers varieties. This partnership is anticipated to advance the event of predictive biomarkers for WEE1-targeted therapies, thereby contributing to extra exact and efficient most cancers remedies.
Is TEM a Good Stock to Buy?
Turning to Wall Avenue, TEM inventory has a Reasonable Purchase consensus ranking primarily based on 5 Buys and two Holds assigned within the final three months. At $61.67, the common Tempus AI inventory value goal implies round 31% draw back potential.